Zurich Cantonal Bank
ODT

Zurich Cantonal Bank’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Zurich Cantonal Bank’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,565
Closed -$5K – 2631
2021
Q1 		$5K Sell
1,565
-1,981
-56% -$37.4K ﹤0.01% 2545
2020
Q4 		$68K Buy
3,546
+2,620
+283% +$40.4K ﹤0.01% 2350
2020
Q3 		$12K Hold
926
– – ﹤0.01% 2537
2020
Q2 		$39K Hold
926
– – ﹤0.01% 2287
2020
Q1 		$26K Hold
926
– – ﹤0.01% 2263
2019
Q4 		$30K Hold
926
– – ﹤0.01% 2388
2019
Q3 		$24K Buy
+926
New +$31K ﹤0.01% 2402

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Zurich Cantonal Bank's ODT Position: Q2 2021 in Review

Zurich Cantonal Bank sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q2 2021, closing a stake of 1,565 shares — an estimated $5K sold.

Zurich Cantonal Bank first reported a position in ODT in Q3 2019 and held it in 7 quarters. The position peaked at $68K in Q4 2020. 69 funds tracked by Wall St. Rank hold ODT as of Q2 2021.

  • Zurich Cantonal Bank reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1,565 Odonate Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $5K.
  • Zurich Cantonal Bank first reported a position in Odonate Therapeutics, Inc. Common Stock in Q3 2019 and held it in 7 quarters.
  • Zurich Cantonal Bank's Odonate Therapeutics, Inc. Common Stock position peaked at $68K in Q4 2020.
  • 69 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Zurich Cantonal Bank's 13F filing for Q2 2021, filed 30 Jul 2021.